Indevr, Inc.

Boulder, CO 80301

SBIR Award Summary

Total Number of Awards 22
Total Value of Awards $14.1MM
First Award Date 09/15/04
Most Recent Award Date 08/01/17

Key Personnel

Last Name Name Awards Contact
Rowlen Kathy L Rowlen 12
Ferris Matthew M. Ferris 5
Dawson Erica D Dawson 5

22 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-287
Budget: 08/01/17 - 07/31/18

DESCRIPTION (provided by applicant): It is widely acknowledged that for split vaccines, potency determination is often a rate limiting step. The FDA approved gold standard potency assay for influenza hemagglutinin (HA) protein-based vaccines is single radial immunodiffusion (SRID). SRID is a time and labor intensive assay, often requiring 2-3 da...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 06/01/17 - 05/31/18

PROJECT SUMMARY The Hemagglutination assay (HA) and Hemagglutination Inhibition (HI) assay are widely used methods for characterizing viruses, bacteria, and antibodies. The World Health Organization recently recommended that HI remain the gold standard method for influenza seroepidemiology. Although the HA and HI assays are applied worldwide, th...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 08/01/16 - 07/31/17

DESCRIPTION (provided by applicant): It is widely acknowledged that for split vaccines, potency determination is often a rate limiting step. The FDA approved gold standard potency assay for influenza hemagglutinin (HA) protein-based vaccines is single radial immunodiffusion (SRID). SRID is a time and labor intensive assay, often requiring 2-3 da...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 06/21/16 - 05/31/17

PROJECT SUMMARYThe Hemagglutination assay (HA) and Hemagglutination Inhibition (HI) assay are widely used methodsfor characterizing viruses, bacteria, and antibodies. The World Health Organization recentlyrecommended that HI remain the gold standard method for influenza seroepidemiology. Although theHA and HI assays are applied worldwide, they h...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 08/01/15 - 07/31/16

DESCRIPTION (provided by applicant): It is widely acknowledged that for split vaccines, potency determination is often a rate limiting step. The FDA approved gold standard potency assay for influenza hemagglutinin (HA) protein-based vaccines is single radial immunodiffusion (SRID). SRID is a time and labor intensive assay, often requiring 2-3 da...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 05/01/15 - 04/30/16

DESCRIPTION (provided by applicant): We propose to eliminate the time-consuming manual plate readout for hemagglutination assays by developing an innovative 96-well plate and associated optical reader capable of accurately and rapidly determining hemagglutination (+/-) and associated titer values in a fully automated system. The need for improve...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 08/01/14 - 07/31/15

DESCRIPTION (provided by applicant): It is widely acknowledged that for split vaccines, potency determination is often a rate limiting step. The FDA approved "gold standard" potency assay for influenza hemagglutinin (HA) protein-based vaccines is single radial immunodiffusion (SRID). SRID is a time and labor intensive assay, often requiring 2-3 ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 05/01/14 - 04/30/15

DESCRIPTION (provided by applicant): We propose to eliminate the time-consuming manual plate readout for hemagglutination assays by developing an innovative 96-well plate and associated optical reader capable of accurately and rapidly determining hemagglutination (+/-) and associated titer values in a fully automated system. The need for improve...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 05/01/13 - 04/30/14

DESCRIPTION (provided by applicant): There is a tremendous need for new analytical methods to enhance vaccine research and development, ultimately allowing the production of safe and efficacious vaccines in less time at less cost. For example, it is well known that for splt vaccines one step in the process that can be rate limiting is protein qu...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 02/01/13 - 01/31/14

DESCRIPTION (provided by applicant): The objective for this Phase II application is to develop a cartridge-based automated molecular diagnostic platform to rapidly and cost-effectively detect and identify influenza viruses. The system will automate all key functions for sample processing including extraction, amplification, colorimetric detectio...

Load More